Distinct UNC13A Haplotype Blocks Define Disease Severity and Survival in Chinese Amyotrophic Lateral Sclerosis
European Journal of Neurology · 2026-06 · 33 (6)
DOI: 10.1111/ene.70653 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 01.06.2026. Verfasst von Cailin He und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xiangya Hospital, Central South University, Jiangxi (National Regional Center for Neurological Diseases), Nanchang, Jiangxi,…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Nerve Tissue Proteins. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the National Key R&D Program of China, National Science and Technology Innovation 2030 Major Program, the National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
UNC13A is a genetic modifier of amyotrophic lateral sclerosis (ALS) in European populations, but its role in Chinese patients remains incompletely characterized. We investigated the spectrum of UNC13A variation and its impact on disease risk and progression in a Chinese ALS cohort.
Methods
We performed an integrated genetic analysis of 1,533 Chinese ALS patients and 1,405 controls, including rare variant burden testing, genome‐wide survival analysis, haplotype mapping, and conditional analyses. An integrated clinical‐genetic prognostic score was developed and validated.
Results
Rare deleterious UNC13A variants were not associated with ALS risk. We identified two independent haplotype blocks with distinct clinical impacts. Block 1 (tagged by rs75421007) was associated with reduced baseline muscle strength ( p = 0.030), while Block 2 (tagged by rs78549703), a brain‐specific splicing QTL, was the primary driver of survival heterogeneity. The European variant rs12608932 showed a survival association in single‐marker analysis ( p = 0.024), but conditional analyses revealed its effect was not independent of Block 2. An integrated prognostic score combining clinical factors and Block 2 haplotype stratified patients into low‐, intermediate‐, and high‐risk groups (median survival: 52.6, 37.1, and 32.0 months; p < 0.001), with decision curve analysis confirming clinical utility.
Conclusions
This study delineates UNC13A genetic architecture in Chinese ALS, identifying two independent haplotype blocks that differentially influence disease severity and survival. The Block 2 haplotype, which includes a brain sQTL, is a major determinant of survival heterogeneity and may inform patient stratification in future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Xiangya Hospital, Central South University, Jiangxi (National Regional Center for Neurological Diseases), Nanchang, Jiangxi, P. R. China.
- National Clinical Research Center for Geriatric Diseases (Xiangya Hospital of Central South University), Changsha, Hunan, P. R. China.
- Key Laboratory of Hunan Province for Neurodegenerative Disorders, Central South University, Changsha, Hunan, P. R. China.
- Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, P. R. China.
- Engineering Research Center of Hunan Province for Cognitive Impairment Disorders, Central South University, Changsha, Hunan, P. R. China.
- Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, Hunan, P. R. China.
ORCID-Profile: Linxin Tang, Renshi Xu, Jifeng Guo, Lu Shen, Beisha Tang, Junling Wang
Förderung
- the National Key R&D Program of China
- National Science and Technology Innovation 2030 Major Program
- the National Natural Science Foundation of China
- the Jiangxi Provincial Natural Science Foundation
- the Ganpo Outstanding Talents Support Program-Cultivation Project for Academic and Technical Leaders in Key Disciplines
- the Ganpo Talents Program-Innovation Leading Talent Project (Medical and Health Care Category)
- the Jiangxi Provincial Health Technology Project
Zitieren
APA
He, C., Liu, Z., Yuan, Y., Tang, L., Wang, M., Li, Y., Zhao, Q., Weng, L., Du, J., Wu, H., Hu, F., Xu, R., Guo, J., Shen, L., Tang, B., & Wang, J. (2026). Distinct UNC13A Haplotype Blocks Define Disease Severity and Survival in Chinese Amyotrophic Lateral Sclerosis. European Journal of Neurology, 33(6). https://doi.org/10.1111/ene.70653
Vancouver
He C, Liu Z, Yuan Y, Tang L, Wang M, Li Y, et al. Distinct UNC13A Haplotype Blocks Define Disease Severity and Survival in Chinese Amyotrophic Lateral Sclerosis. European Journal of Neurology. 2026;33(6). doi:10.1111/ene.70653
BibTeX
@article{He2026,
author = {He, Cailin and Liu, Ziqin and Yuan, Yanchun and Tang, Linxin and Wang, Meirong and Li, Yongchao and Zhao, Qianqian and Weng, Ling and Du, Juan and Wu, Hanjun and Hu, Fan and Xu, Renshi and Guo, Jifeng and Shen, Lu and Tang, Beisha and Wang, Junling},
title = {Distinct UNC13A Haplotype Blocks Define Disease Severity and Survival in Chinese Amyotrophic Lateral Sclerosis},
journal = {European Journal of Neurology},
year = {2026},
volume = {33},
number = {6},
doi = {10.1111/ene.70653}
}
EUVIMED